[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Vaccine Contract Manufacturing Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: GDEFA96EFB40EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Vaccine Contract Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vaccine Contract Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
  • Diosynth
  • Emergent BioSolutions
  • Goodwin Biotechnology
  • Bavarian Nordic
  • Soligenix Inc
  • Catalent Biologics
  • ...
Market segment by Type, the product can be split into
  • Fill-Finish
  • Bulk Product
Market segment by Application, split into
  • Pharmaceutical Companies
  • Biotech Companies
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Vaccine Contract Manufacturing status, future forecast, growth opportunity, key market and key players.
  • To present the Vaccine Contract Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Vaccine Contract Manufacturing are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
1.4 Market Analysis by Type
  1.4.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Fill-Finish
  1.4.3 Bulk Product
1.5 Market by Application
  1.5.1 Global Vaccine Contract Manufacturing Market Share by Application: 2020 VS 2026
  1.5.2 Pharmaceutical Companies
  1.5.3 Biotech Companies
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Vaccine Contract Manufacturing Market Perspective (2015-2026)
2.2 Vaccine Contract Manufacturing Growth Trends by Regions
  2.2.1 Vaccine Contract Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Vaccine Contract Manufacturing Historic Market Share by Regions (2015-2020)
  2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Vaccine Contract Manufacturing Market Growth Strategy
  2.3.6 Primary Interviews with Key Vaccine Contract Manufacturing Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Vaccine Contract Manufacturing Players by Market Size
  3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2015-2020)
  3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Vaccine Contract Manufacturing Market Concentration Ratio
  3.2.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2019
3.3 Vaccine Contract Manufacturing Key Players Head office and Area Served
3.4 Key Players Vaccine Contract Manufacturing Product Solution and Service
3.5 Date of Enter into Vaccine Contract Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2021-2026)

5 VACCINE CONTRACT MANUFACTURING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Vaccine Contract Manufacturing Market Size by Application (2015-2020)
5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Vaccine Contract Manufacturing Market Size (2015-2020)
6.2 Vaccine Contract Manufacturing Key Players in North America (2019-2020)
6.3 North America Vaccine Contract Manufacturing Market Size by Type (2015-2020)
6.4 North America Vaccine Contract Manufacturing Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Vaccine Contract Manufacturing Market Size (2015-2020)
7.2 Vaccine Contract Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Vaccine Contract Manufacturing Market Size by Type (2015-2020)
7.4 Europe Vaccine Contract Manufacturing Market Size by Application (2015-2020)

8 CHINA

8.1 China Vaccine Contract Manufacturing Market Size (2015-2020)
8.2 Vaccine Contract Manufacturing Key Players in China (2019-2020)
8.3 China Vaccine Contract Manufacturing Market Size by Type (2015-2020)
8.4 China Vaccine Contract Manufacturing Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Vaccine Contract Manufacturing Market Size (2015-2020)
9.2 Vaccine Contract Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Vaccine Contract Manufacturing Market Size by Type (2015-2020)
9.4 Japan Vaccine Contract Manufacturing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Vaccine Contract Manufacturing Market Size (2015-2020)
10.2 Vaccine Contract Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Vaccine Contract Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Vaccine Contract Manufacturing Market Size by Application (2015-2020)

11 INDIA

11.1 India Vaccine Contract Manufacturing Market Size (2015-2020)
11.2 Vaccine Contract Manufacturing Key Players in India (2019-2020)
11.3 India Vaccine Contract Manufacturing Market Size by Type (2015-2020)
11.4 India Vaccine Contract Manufacturing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Vaccine Contract Manufacturing Market Size (2015-2020)
12.2 Vaccine Contract Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Vaccine Contract Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Vaccine Contract Manufacturing Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Diosynth
  13.1.1 Diosynth Company Details
  13.1.2 Diosynth Business Overview and Its Total Revenue
  13.1.3 Diosynth Vaccine Contract Manufacturing Introduction
  13.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2015-2020))
  13.1.5 Diosynth Recent Development
13.2 Emergent BioSolutions
  13.2.1 Emergent BioSolutions Company Details
  13.2.2 Emergent BioSolutions Business Overview and Its Total Revenue
  13.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
  13.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2015-2020)
  13.2.5 Emergent BioSolutions Recent Development
13.3 Goodwin Biotechnology
  13.3.1 Goodwin Biotechnology Company Details
  13.3.2 Goodwin Biotechnology Business Overview and Its Total Revenue
  13.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
  13.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2015-2020)
  13.3.5 Goodwin Biotechnology Recent Development
13.4 Bavarian Nordic
  13.4.1 Bavarian Nordic Company Details
  13.4.2 Bavarian Nordic Business Overview and Its Total Revenue
  13.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
  13.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2015-2020)
  13.4.5 Bavarian Nordic Recent Development
13.5 Soligenix Inc
  13.5.1 Soligenix Inc Company Details
  13.5.2 Soligenix Inc Business Overview and Its Total Revenue
  13.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
  13.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2015-2020)
  13.5.5 Soligenix Inc Recent Development
13.6 Catalent Biologics
  13.6.1 Catalent Biologics Company Details
  13.6.2 Catalent Biologics Business Overview and Its Total Revenue
  13.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
  13.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2015-2020)
  13.6.5 Catalent Biologics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Vaccine Contract Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
Table 3. Ranking of Global Top Vaccine Contract Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fill-Finish
Table 6. Key Players of Bulk Product
Table 7. Global Vaccine Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Vaccine Contract Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Vaccine Contract Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Vaccine Contract Manufacturing Market Share by Regions (2015-2020)
Table 11. Global Vaccine Contract Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Vaccine Contract Manufacturing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Vaccine Contract Manufacturing Market Growth Strategy
Table 17. Main Points Interviewed from Key Vaccine Contract Manufacturing Players
Table 18. Global Vaccine Contract Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Vaccine Contract Manufacturing Market Share by Players (2015-2020)
Table 20. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Contract Manufacturing as of 2019)
Table 21. Global Vaccine Contract Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Vaccine Contract Manufacturing Product Solution and Service
Table 24. Date of Enter into Vaccine Contract Manufacturing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Vaccine Contract Manufacturing Market Size Share by Type (2015-2020)
Table 28. Global Vaccine Contract Manufacturing Revenue Market Share by Type (2021-2026)
Table 29. Global Vaccine Contract Manufacturing Market Size Share by Application (2015-2020)
Table 30. Global Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Vaccine Contract Manufacturing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 34. North America Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 36. North America Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 38. Europe Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 40. Europe Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 42. Europe Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 44. China Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 46. China Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 47. China Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 48. China Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 49. China Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 50. Japan Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 52. Japan Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 54. Japan Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 58. Southeast Asia Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 60. Southeast Asia Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 62. India Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 64. India Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 65. India Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 66. India Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 67. India Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Vaccine Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Vaccine Contract Manufacturing Market Share (2019-2020)
Table 70. Central & South America Vaccine Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Vaccine Contract Manufacturing Market Share by Type (2015-2020)
Table 72. Central & South America Vaccine Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Vaccine Contract Manufacturing Market Share by Application (2015-2020)
Table 74. Diosynth Company Details
Table 75. Diosynth Business Overview
Table 76. Diosynth Product
Table 77. Diosynth Revenue in Vaccine Contract Manufacturing Business (2015-2020) (Million US$)
Table 78. Diosynth Recent Development
Table 79. Emergent BioSolutions Company Details
Table 80. Emergent BioSolutions Business Overview
Table 81. Emergent BioSolutions Product
Table 82. Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2015-2020) (Million US$)
Table 83. Emergent BioSolutions Recent Development
Table 84. Goodwin Biotechnology Company Details
Table 85. Goodwin Biotechnology Business Overview
Table 86. Goodwin Biotechnology Product
Table 87. Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2015-2020) (Million US$)
Table 88. Goodwin Biotechnology Recent Development
Table 89. Bavarian Nordic Company Details
Table 90. Bavarian Nordic Business Overview
Table 91. Bavarian Nordic Product
Table 92. Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2015-2020) (Million US$)
Table 93. Bavarian Nordic Recent Development
Table 94. Soligenix Inc Company Details
Table 95. Soligenix Inc Business Overview
Table 96. Soligenix Inc Product
Table 97. Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2015-2020) (Million US$)
Table 98. Soligenix Inc Recent Development
Table 99. Catalent Biologics Company Details
Table 100. Catalent Biologics Business Overview
Table 101. Catalent Biologics Product
Table 102. Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2015-2020) (Million US$)
Table 103. Catalent Biologics Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Vaccine Contract Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Fill-Finish Features
Figure 3. Bulk Product Features
Figure 4. Global Vaccine Contract Manufacturing Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Companies Case Studies
Figure 6. Biotech Companies Case Studies
Figure 7. Others Case Studies
Figure 8. Vaccine Contract Manufacturing Report Years Considered
Figure 9. Global Vaccine Contract Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Vaccine Contract Manufacturing Market Share by Regions: 2020 VS 2026
Figure 11. Global Vaccine Contract Manufacturing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Vaccine Contract Manufacturing Market Share by Players in 2019
Figure 14. Global Top Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Contract Manufacturing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Vaccine Contract Manufacturing Revenue in 2019
Figure 16. North America Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Vaccine Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Diosynth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Diosynth Revenue Growth Rate in Vaccine Contract Manufacturing Business (2015-2020)
Figure 25. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Emergent BioSolutions Revenue Growth Rate in Vaccine Contract Manufacturing Business (2015-2020)
Figure 27. Goodwin Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Goodwin Biotechnology Revenue Growth Rate in Vaccine Contract Manufacturing Business (2015-2020)
Figure 29. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bavarian Nordic Revenue Growth Rate in Vaccine Contract Manufacturing Business (2015-2020)
Figure 31. Soligenix Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Soligenix Inc Revenue Growth Rate in Vaccine Contract Manufacturing Business (2015-2020)
Figure 33. Catalent Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Catalent Biologics Revenue Growth Rate in Vaccine Contract Manufacturing Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed


More Publications